The authors have indicated no significant interest with commercial supporters.
Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook
Version of Record online: 7 JAN 2013
© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Volume 39, Issue 6, pages 839–848, June 2013
How to Cite
Bloom, B. S., Brauer, J. A. and Geronemus, R. G. (2013), Ablative Fractional Resurfacing in Topical Drug Delivery: An Update and Outlook. Dermatologic Surgery, 39: 839–848. doi: 10.1111/dsu.12111
- Issue online: 5 JUN 2013
- Version of Record online: 7 JAN 2013
The effective delivery of therapeutic molecules to varied targets in the skin and elsewhere has been an area of ongoing research and development.
To review the structure of the skin with an emphasis on topical drug delivery and to present the rationale for the use of ablative and nonablative fractional resurfacing in assisted drug delivery.
Methods and Materials
Review of the currently available scientific literature on laser-assisted drug delivery.
A number of strategies can be employed to enhance topical drug delivery. Ablative fractional resurfacing (AFR) has been demonstrated to be effective in enhancing drug delivery. Further studies are needed to assess the use of nonablative fractional resurfacing in assisted drug delivery.
AFR-assisted drug delivery is a promising tool for the future of dermatology. We expect to see a number of agents to be paired with AFR for enhanced drug delivery. Further investigation is necessary to evaluate appropriate drug specific channel density and depth parameters. Factors that must be considered include the physicochemical properties of the drug, the target tissue, skin wounding, and cost when evaluating the drugs and conditions that will most benefit from this promising new drug delivery system.